Evidence map›Paper›PMID 12163469›Full record

ArticleThe Journal of cell biology2002

Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies.

Beata Fuchsová, Petr Novák, Jarmila Kafková, Pavel Hozák

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Nuclear actin and myosins in adenovirus infection.Experimental cell research · 2015
    Article
  12. Review
  13. Review
  14. Article
  15. PML nuclear bodies.Cold Spring Harbor perspectives in biology · 2010
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Quantitative analysis of cell nucleus organisation.PLoS computational biology · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Beata FuchsováDepartment of Cell Ultrastructure and Molecular Biology, Institute of Experimental Medicine, Academy of the Czech Republic, Czech Republic.
Petr Novák
Jarmila Kafková
Pavel Hozák
Czech Academy of Sciences, Institute of Experimental Medicine · CZCzech Academy of Sciences, Institute of Microbiology · CZInstitute of Rheumatology · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is known that nuclear DNA helicase II (NDH II) links CREB-binding protein directly to RNA polymerase II holoenzyme, and that this interaction is essential for gene activation by CREB. Here, we report for the first time that some NDH II/RNA helicase A is a component of promyelocytic leukemia nuclear bodies (PML NBs). An autoimmune serum specific for PML NBs was identified and used in immunoprecipitation experiments. NDH II was present in the immunoprecipitates as shown by mass spectrometry and by immunoblotting. Immunofluorescence and ultrastructural studies showed that NDH II colocalizes with a small subset of PML NBs in control cells, however, colocalizes with practically all bodies in interferon-alpha-stimulated cells. After interferon stimulation, more PML NBs were found to contain newly synthesized RNA, as indicated by bromouridine incorporation. PML NBs also contain RNA polymerase II. The association of NDH II with PML NBs was transcriptionally dependent, and NDH II was present in all bodies with nascent RNA. Blocking of mRNA synthesis caused NDH II relocalization from nucleoplasm to nucleoli. Based on the data, we suggest that NDH II recruitment to PML NBs is connected with transcriptional regulation of interferon-alpha-inducible genes attached to PML NBs.

Indexed as

Nuclear ProteinsAdenosine TriphosphatasesAmanitinsAutoimmune DiseasesBlood ProteinsCell Nucleus StructuresDNADNA HelicasesEukaryotic CellsHeLa CellsHumansImmunohistochemistryInterferon-alphaMacromolecular SubstancesMicroscopy, ElectronNeoplasm ProteinsAdenosine TriphosphatasesAmanitinsBlood ProteinsDNADNA HelicasesInterferon-alphaMacromolecular SubstancesNeoplasm ProteinsNuclear ProteinsNucleic Acid Synthesis InhibitorsPML protein, humanPromyelocytic Leukemia ProteinRNA, MessengerTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID12163469
PMCPMC2173842
OpenAlexW1986094835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.